Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × aflibercept × Clear all

NCT00828139 2017-08-21

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Phase 2 Completed

189 enrolled 15 charts

Small Cell Lung Carcinoma